{"entity":{"type":"insider","cik":"0001862082","url":"/insider/0001862082","json_url":"/insider/0001862082.json","name":"Tupper Colleen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2022-10-06","last":"2025-11-07","span_basis":"filed_date"},"name_variants":[{"name":"Tupper Colleen","source":"filing","n_filings":8,"first_seen":"2022-10-06","last_seen":"2025-11-07"}],"transactions":[{"id":4361075,"accession":"0001862082-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001862082-25-000004","line_url":"/filing/0001862082-25-000004","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":40.5251113,"price_display":"40.53","price_state":"stated","total_value":1215753.339,"total_display":"1,215,753.34","total_whole":"1,215,753","shares_owned_after":131525.0,"shares_owned_after_display":"131,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-06","filed_date":"2025-11-07","scope":"insider","n_lines":2},{"id":4529480,"accession":"0001062993-25-006149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-006149","line_url":"/filing/0001062993-25-006149#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6396.0,"shares_display":"6,396","price_per_share":30.0295,"price_display":"30.03","price_state":"stated","total_value":192068.682,"total_display":"192,068.68","total_whole":"192,069","shares_owned_after":156667.0,"shares_owned_after_display":"156,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4529468,"accession":"0001062993-25-006149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-006149","line_url":"/filing/0001062993-25-006149#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1206.0,"shares_display":"1,206","price_per_share":30.0011,"price_display":"30.00","price_state":"stated","total_value":36181.3266,"total_display":"36,181.33","total_whole":"36,181","shares_owned_after":163063.0,"shares_owned_after_display":"163,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":4794274,"accession":"0001062993-25-005753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005753","line_url":"/filing/0001062993-25-005753#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":977.0,"shares_display":"977","price_per_share":30.0034,"price_display":"30.00","price_state":"stated","total_value":29313.3218,"total_display":"29,313.32","total_whole":"29,313","shares_owned_after":164269.0,"shares_owned_after_display":"164,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":4762100,"accession":"0001062993-25-005395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005395","line_url":"/filing/0001062993-25-005395#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10445.0,"shares_display":"10,445","price_per_share":30.006,"price_display":"30.01","price_state":"stated","total_value":313412.67,"total_display":"313,412.67","total_whole":"313,413","shares_owned_after":165246.0,"shares_owned_after_display":"165,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":4794215,"accession":"0001062993-25-005021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-005021","line_url":"/filing/0001062993-25-005021#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1504.0,"shares_display":"1,504","price_per_share":30.0007,"price_display":"30.00","price_state":"stated","total_value":45121.0528,"total_display":"45,121.05","total_whole":"45,121","shares_owned_after":175691.0,"shares_owned_after_display":"175,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-10","scope":"insider"},{"id":4794210,"accession":"0001062993-25-005021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005021","line_url":"/filing/0001062993-25-005021#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1949.0,"shares_display":"1,949","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":58470.0,"total_display":"58,470.00","total_whole":"58,470","shares_owned_after":177195.0,"shares_owned_after_display":"177,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-10","scope":"insider"},{"id":2212094,"accession":"0001062993-24-011413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-011413","line_url":"/filing/0001062993-24-011413#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19710.0,"shares_display":"19,710","price_per_share":34.2145,"price_display":"34.21","price_state":"stated","total_value":674367.795,"total_display":"674,367.80","total_whole":"674,368","shares_owned_after":130845.0,"shares_owned_after_display":"130,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-29","scope":"insider"},{"id":8041458,"accession":"0001062993-23-007174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-007174","line_url":"/filing/0001062993-23-007174#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31640.0,"shares_display":"31,640","price_per_share":23.7726,"price_display":"23.77","price_state":"stated","total_value":752165.064,"total_display":"752,165.06","total_whole":"752,165","shares_owned_after":105420.0,"shares_owned_after_display":"105,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider"},{"id":6170251,"accession":"0001062993-22-020614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-020614","line_url":"/filing/0001062993-22-020614#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001862082","owner_name":"Tupper Colleen","owner_display_name":"Tupper Colleen","owner_url":"/insider/0001862082","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4350.0,"shares_display":"4,350","price_per_share":17.35,"price_display":"17.35","price_state":"stated","total_value":75472.5,"total_display":"75,472.50","total_whole":"75,473","shares_owned_after":90304.0,"shares_owned_after_display":"90,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Officer (EVP & Chief Financial Officer)","n_filings":8,"first_seen":"2022-10-06","last_seen":"2025-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001862082","retrieved_at":"2026-08-24T00:59:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}